KCTD17 p.Pro299=
c.897C>T · rs116956945 · VCV476040
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
|---|---|---|
| Constraint at this position | ||
| Conservation | phyloP 1.6 | GERP -1.2, phastCons 1 |
| Overall | ||
| CADD | 13.06 | PHRED · no single calibrated threshold — expert panels disagree |
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Amishnot grpmax-eligible | 9.01% | 11 |
| Middle Easterngrpmax | 6.73% | 15 |
| European (non-Finnish) | 5.64% | 18 |
| South Asian | 4.47% | 22 |
| Remaining individualsnot grpmax-eligible | 4.32% | 23 |
| Admixed American | 2.74% | 37 |
| Ashkenazi Jewishnot grpmax-eligible | 2.51% | 40 |
| Finnishnot grpmax-eligible | 1.91% | 52 |
| African / African-American | 0.905% | 111 |
| East Asian | 0.0178% | 5,606 |
Amish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- KCTD17
- Protein
- p.Pro299=
- Coding
- c.897C>T
- MANE Select
- NM_001282684
- dbSNP
- rs116956945
- Type
- single nucleotide variant
- Location
- chr22:37062546 (GRCh38)
- Gene constraint
- LOEUF 0.928 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 71.59 · 1 PDB
Disease context
myoclonic dystonia 26 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Myoclonus-dystonia syndrome (Orphanet):
- Inheritance
- Autosomal dominant, Not applicable
- Onset
- Adolescent, Adult, Childhood
- Prevalence
- 1-9 / 1 000 000 (Europe)
Similar variants
- KCTD17 p.Arg138His Pathogenic ★★ same condition
- KCTD17 c.486+5G>A Uncertain significance ★★ same condition
- KCTD17 p.Ala12Val Uncertain significance ★★ ⚠ same condition
- KCTD17 p.Ala298Thr Uncertain significance ★★ ⚠ same condition
- KCTD17 p.Arg159Cys Uncertain significance ★★ same condition
- KCTD17 p.Arg264Cys Uncertain significance ★★ ⚠ same condition
- KCTD17 p.Arg281Pro Uncertain significance ★★ ⚠ same condition
- KCTD17 p.Glu146Lys Uncertain significance ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/kctd17-p-pro299 (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown